The UK Chemotherapy Board has issued new guidance on: Monitoring of blood sugar levels on patients on SACT or steroids The ambulatory pathway for patients presenting with LRFN Previous Post ACP McElwain and President's Prizes 2021 Next Post Join the ACP for the Best of ASCO® 2021 - Monday 5th July 4.00-6.30pm
